Penn Leads NSF Sponsored AIRFoundry to Revolutionize RNA Research, Leveraging AI to Further Optimize and Innovate
It is an $18-million initiative focused on advancing RNA research through AI-driven innovation and advanced manufacturing techniques.
Penn spinout Linnaeus Therapeutics secures an additional $1.6M in Funding
Penn spinout Linnaeus Therapeutics has raised another $1.6 million in financing, bringing its cumulative funding total to over $13 million since 2018.
iECURE included on list of Fierce Biotech’s 2024 Fierce 15
iECURE was recognized for its innovative approach to treating rare childhood diseases by developing therapies that correct gene function directly inside the body.
Penn Spinout Interius BioTherapeutics Raises Additional $67M and doses first patient
The company’s approach focuses on creating cancer-fighting cells directly inside the body, potentially bypassing the need for external cell manipulation and chemotherapy.
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
Carisma has expanded its collaboration with Moderna to develop two chimeric antigen receptor macrophage (CAR-M) targets for autoimmune disease treatment.
Dr. James Wilson takes on roles in two new companies spun out of Penn’s Gene Therapy Program
James Wilson, MD, PhD, has left Penn after 33 years to take on leadership roles in two independent startups that he co-founded.
Penn Medicine and Parker Institute renew alliance to continue groundbreaking cancer immunotherapy research
The continued collaboration will support laboratory studies and clinical trials that leverage the science of cancer immunology.
Penn Medicine researchers use AI to uncover potential antibiotic compounds
This groundbreaking study, published in Cell, represents the largest antibiotic discovery effort to date, significantly accelerating the process of identification of candidate molecules.
Penn Researchers Study New Treatment Options for Brain Cancer Patients
A team of Penn researchers are exploring whether MRIs that measure the "temperature" of tumors could enhance treatment for glioblastoma, a deadly brain cancer.
EpiVario Awarded NIH Grant to Advance Research in Treatments for Cocaine Use Disorder
EpiVario is developing neuroepigenetic modulators to treat memory-related addiction and psychiatric disorders.